Evidence map›Paper›PMID 39552480›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2024

Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure.

Martin Andreas, Tillmann Kerbel, Markus Mach, Andreas Zierer, Elmar Kuhn, Jude S Sauer, Hendrik Ruge, Ander Reguiero, Andrea Colli

Abstract readMulticenter Study
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Martin AndreasDepartment of Cardiac Surgery, Medical University Vienna, Vienna, Austria.
Tillmann KerbelDepartment of Cardiac Surgery, Medical University Vienna, Vienna, Austria.
Markus MachDepartment of Cardiac Surgery, Medical University Vienna, Vienna, Austria.
Andreas ZiererDepartment of Cardiac, Vascular, and Thoracic Surgery, Kepler University Hospital, Linz, Austria.
Elmar KuhnDepartment of Cardiothoracic Surgery, Heart Center, University of Cologne, Cologne, Germany.
Jude S SauerLSI Solutions, Inc., Victor, NY, USA.
Hendrik RugeDepartment of Cardiovascular Surgery, Institute Insure, German Heart Centre Munich, School of Medicine & Health, Technical University of Munich, Munich, Germany.
Ander ReguieroDepartment of Cardiology, Hospital Clinic de Barcelona, Barcelona, Spain.
Andrea ColliDepartment of Cardiac Surgery, Medical University Pisa, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe MitraCut procedure employs beating heart transapical (TA) cannulation and endoscopic scissors for dividing the anterior mitral leaflet (AML) to prevent left ventricular outflow tract (LVOT) obstruction in transapical transcatheter mitral valve replacement (TA-TMVR).

aimsWe present the first multicentre experience of the MitraCut procedure prior to TA-TMVR to prevent LVOT obstruction.

methodsIn 6 European centres, the clinical outcomes of all 13 high-risk patients who had undergone the MitraCut procedure during TA-TMVR procedures were retrospectively reviewed regarding technical success, procedural details and outcome.

resultsThe MitraCut procedure was successfully completed in 11 patients with 1 cutting attempt, while 2 patients had 2 cutting attempts, with an average procedure duration of 9.0±5.4 min. No patient demonstrated postoperative LVOT obstruction, and all mitral valve (MV) prostheses were competent throughout the follow-up period. However, 1 patient developed a MitraCut-related paravalvular leak (PVL; technical success rate: 12/13). The mean LVOT gradient was 3.9±4.4 mmHg directly after valve expansion and 3.6±3.1 mmHg at follow-up. In-hospital and 30-day mortality were 0%. One patient experiencing MitraCut-related PVL was successfully treated by interventional PVL closure (reintervention rate: n=1). One patient died at 47 days due to cardiac arrhythmia, unrelated to the AML-directed procedure. The mean follow-up at the time of data analysis was 52±34 days.

conclusionsThe MitraCut procedure was effective and reproducible for preventing potential LVOT obstruction in TA-TMVR patients during its initial exploration in 6 European hospitals. Considerations regarding the scissors' characteristics, their handling and cut length are mandatory for safe performance of the procedure.

Indexed as

Cardiac CatheterizationHeart Valve Prosthesis ImplantationMitral ValveMitral Valve InsufficiencyVentricular Outflow ObstructionAgedAged, 80 and overFemaleHeart Valve ProsthesisHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeVentricular Outflow Obstruction, Left

Identifiers

PMID39552480
PMCPMC11556404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.